Literature DB >> 15943598

Immediate allergic reactions to cephalosporins and penicillins and their cross-reactivity in children.

Marina Atanasković-Marković1, Tanja Cirković Velicković, Marija Gavrović-Jankulović, Olja Vucković, Branimir Nestorović.   

Abstract

Penicillins and cephalosporins are the most important betalactams inducing IgE-mediated reactions. The safety of administering cephalosporins to penicillin-allergic children is a particular problem, because cephalosporin allergenic determinants have not been properly identified. A study was undertaken to evaluate the frequency of anaphylactic reactions to cephalosporins and penicillins and their cross-reactivity in a pediatric population. A prospective survey was conducted in a group of 1170 children with suspected immediate allergic reactions to cephalosporins and/or penicillins, which were examined during a period of 8 yr. In vivo (skin tests and challenges) and in vitro tests (for specific IgE) were performed with standard concentration of penicillins and cephalosporins. When 1170 children with a clinical history of allergy to penicillins and/or cephalosporins were tested in vivo for immediate hypersensitivity to betalactams, 58.3% cases overall were found to be skin or challenge test positive. Among them, 94.4% patients were positive to penicillins and 35.3% to cephalosporins. The frequency of positive reactions in the in vivo testing was in the range from 36.4% to 88.1% for penicillins and from 0.3% to 29.2% for cephalosporins. However, 31.5% of the penicillin allergic children cross-reacted to some cephalosporin. If a child was allergic to a cephalosporin, the frequency of positive reactions to penicillin was 84.2%. The cross-reactivity between cephalosporins and penicillins varied between 0.3% and 23.9%. The cross-reactivity among different generations of cephalosporins varied between 0% and 68.8%, being the highest for first and second-generation cephalosporins and 0% for third generation cephalosporins. The frequency of immediate allergic reactions to cephalosporins is considerably lower compared to penicillins, and the degree of cross-reactivity between cephalosporins and penicillins depends on the generation of cephalosporins, being higher with earlier generation cephalosporins. The cross-reactivity among cephalosporins is lower compared to cross-reactivity between penicillins and cephalosporins.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15943598     DOI: 10.1111/j.1399-3038.2005.00280.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  11 in total

1.  What is the risk of using a cephalosporin in a patient with a penicillin allergy?

Authors:  Alana Cormier; Michael J Rieder; Doreen Matsui
Journal:  Paediatr Child Health       Date:  2007-05       Impact factor: 2.253

Review 2.  Antibiotic Allergy in Pediatrics.

Authors:  Allison Eaddy Norton; Katherine Konvinse; Elizabeth J Phillips; Ana Dioun Broyles
Journal:  Pediatrics       Date:  2018-05       Impact factor: 7.124

3.  Diagnostic evaluation and risk factors for drug allergies in children: from clinical history to skin and challenge tests.

Authors:  Tugba Arikoglu; Gulen Aslan; Sehra Birgul Batmaz; Gulcin Eskandari; Ilter Helvaci; Semanur Kuyucu
Journal:  Int J Clin Pharm       Date:  2015-03-31

4.  The facts about penicillin allergy: a review.

Authors:  Sanjib Bhattacharya
Journal:  J Adv Pharm Technol Res       Date:  2010-01

Review 5.  'Cephalosporin allergy' label is misleading.

Authors:  Carlo L Yuson; Constance H Katelaris; William B Smith
Journal:  Aust Prescr       Date:  2018-04-03

Review 6.  Adverse reaction to ceftriaxone in a 28-day-old infant undergoing urgent craniotomy due to epidural hematoma: review of neonatal biliary pseudolithiasis.

Authors:  Alicja Bartkowska-Śniatkowska; Katarzyna Jończyk-Potoczna; Marzena Zielińska; Jowita Rosada-Kurasińska
Journal:  Ther Clin Risk Manag       Date:  2015-07-02       Impact factor: 2.423

7.  Immunologic evaluation of immediate hypersensitivity to cefaclor.

Authors:  Hye-Soo Yoo; Seung-Hyun Kim; Hyouk-Soo Kwon; Tae-Bum Kim; Young-Hee Nam; Young-Min Ye; Hae-Sim Park
Journal:  Yonsei Med J       Date:  2014-11       Impact factor: 2.759

Review 8.  Pro and Contra: Provocation Tests in Drug Hypersensitivity.

Authors:  Ozge Soyer; Umit Murat Sahiner; Bulent Enis Sekerel
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923

Review 9.  Severe community-acquired pneumonia.

Authors:  Wendy I Sligl; Thomas J Marrie
Journal:  Crit Care Clin       Date:  2013-07       Impact factor: 3.598

10.  Proper Cut-off Levels of Serum Specific IgE to Cefaclor for Patients with Cefaclor Allergy.

Authors:  Young Hee Nam; So Hee Lee; Hyo In Rhyou; Young Soo Lee; Seung Hee Park; Young Hee Lee; Yoo Seob Shin; Hae Sim Park; Young Min Ye
Journal:  Yonsei Med J       Date:  2018-10       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.